US20140162982A1 - Topical compositions for use in the prevention and/or treatment of dermatitis - Google Patents

Topical compositions for use in the prevention and/or treatment of dermatitis Download PDF

Info

Publication number
US20140162982A1
US20140162982A1 US14/130,513 US201214130513A US2014162982A1 US 20140162982 A1 US20140162982 A1 US 20140162982A1 US 201214130513 A US201214130513 A US 201214130513A US 2014162982 A1 US2014162982 A1 US 2014162982A1
Authority
US
United States
Prior art keywords
dermatitis
treatment
psoriasis
prevention
topical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/130,513
Other languages
English (en)
Inventor
Carmelo Cutrupi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of US20140162982A1 publication Critical patent/US20140162982A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/025—Halogenated hydrocarbons carbocyclic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A61K31/035—Halogenated hydrocarbons having aliphatic unsaturation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/695—Silicon compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics

Definitions

  • the present invention relates to the use of topical compositions containing bromociclen for the prevention and/or treatment of dermatitis.
  • compositions containing bromociclen are useful in the prevention and/or treatment of dermatitis.
  • compositions are administered topically.
  • the preferred dosage forms are, for example, solutions, lotions, gels, creams, ointments, shampoos, impregnated bandages and other suitable dosage forms according to the International Pharmacopoeia.

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
US14/130,513 2011-07-06 2012-05-15 Topical compositions for use in the prevention and/or treatment of dermatitis Abandoned US20140162982A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IT001260A ITMI20111260A1 (it) 2011-07-06 2011-07-06 Composizioni topiche per l'uso nella prevenzione e/o nel trattamento di dermatiti
ITMI2011A001260 2011-07-06
PCT/EP2012/058974 WO2013004422A1 (fr) 2011-07-06 2012-05-15 Compositions topiques destinées à être utilisées dans la prévention et/ou le traitement de la dermatite

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2012/058974 A-371-Of-International WO2013004422A1 (fr) 2011-07-06 2012-05-15 Compositions topiques destinées à être utilisées dans la prévention et/ou le traitement de la dermatite

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US14/588,480 Continuation US9144554B2 (en) 2011-07-06 2015-01-02 Topical compositions for use in the prevention and/or treatment of dermatitis

Publications (1)

Publication Number Publication Date
US20140162982A1 true US20140162982A1 (en) 2014-06-12

Family

ID=44898770

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/130,513 Abandoned US20140162982A1 (en) 2011-07-06 2012-05-15 Topical compositions for use in the prevention and/or treatment of dermatitis
US14/588,480 Expired - Fee Related US9144554B2 (en) 2011-07-06 2015-01-02 Topical compositions for use in the prevention and/or treatment of dermatitis

Family Applications After (1)

Application Number Title Priority Date Filing Date
US14/588,480 Expired - Fee Related US9144554B2 (en) 2011-07-06 2015-01-02 Topical compositions for use in the prevention and/or treatment of dermatitis

Country Status (6)

Country Link
US (2) US20140162982A1 (fr)
EP (1) EP2729137B1 (fr)
CA (1) CA2840918C (fr)
ES (1) ES2544543T3 (fr)
IT (1) ITMI20111260A1 (fr)
WO (1) WO2013004422A1 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10201831B2 (en) 2015-12-09 2019-02-12 General Electric Company Coating inspection method

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070020304A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Non-flammable insecticide composition and uses thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2245465T3 (es) * 1996-09-18 2006-01-01 Applied Genetics Incorporated Dermatics Dioles de compuestos de norborneno y norbornano para el tratamiento de trastornos de la pigmentacion, enfermedades neurodegenerativas o enfermedades proliferativas de la piel.
GB2365769A (en) * 2000-08-18 2002-02-27 Secr Defence Skin preparations containing silicon
US20080292560A1 (en) * 2007-01-12 2008-11-27 Dov Tamarkin Silicone in glycol pharmaceutical and cosmetic compositions with accommodating agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070020304A1 (en) * 2002-10-25 2007-01-25 Foamix Ltd. Non-flammable insecticide composition and uses thereof

Also Published As

Publication number Publication date
CA2840918C (fr) 2019-06-18
CA2840918A1 (fr) 2013-01-10
US20150126476A1 (en) 2015-05-07
US9144554B2 (en) 2015-09-29
WO2013004422A1 (fr) 2013-01-10
EP2729137A1 (fr) 2014-05-14
EP2729137B1 (fr) 2015-07-08
ES2544543T3 (es) 2015-09-01
ITMI20111260A1 (it) 2013-01-07

Similar Documents

Publication Publication Date Title
US20140057881A1 (en) Composition for the Treatment of Skin Conditions
AU2014233362A1 (en) Topical compositions of flunisolide and methods of treatment
AU2022205208A1 (en) Use of oxygenated cholesterol sulfates (OCS) to treat inflammatory skin disease and skin lesions
JP2022546928A (ja) カンナビジオールを含む局所製剤、組成物の調製方法およびその使用
US20100130568A1 (en) Topical compositions comprising telmesteine for treating dermatological disorders
US6613800B1 (en) Method and compositions for treating psoriasis, eczema, seborrhea and arthritis
US20060205699A1 (en) Topical treatment for psoriasis
JP6185575B2 (ja) 皮膚炎症性疾患の治療方法
US9144554B2 (en) Topical compositions for use in the prevention and/or treatment of dermatitis
EP0484112A2 (fr) Utilisation du lithium dans le traitement ou la prophylaxie du Molluscum contagiosum
US10350190B2 (en) Method and compositions for treatment and prevention of broad spectrum virus ailments comprising a calcium channel blocker or a calmodulin blocker
EP2934520B1 (fr) Utilisation du pidotimod pour traiter la dermatite atopique
WO2016181355A1 (fr) Compositions pour le traitement et/ou la prévention du psoriasis, de l'éruption sudorale, des dermatites, de la neurofibromatose de type 1 et d'autres pathologies du derme, des muqueuses, et de la cavité buccale
US11234959B2 (en) Compositions comprising a compound of the avermectin family for the treatment and/or prevention of hand eczema
US20170136015A1 (en) Pharmaceutical compositions for the treatment of psoriasis
Murina et al. Vulvar Dermatoses: Effect of a Synergistic Treatment with a Moisturizing and Healing Product on the Course of the Disease
SIGEL Cutaneous diseases among army personnel in Japan
EP3980021A1 (fr) Procédés de traitement et/ou de prévention du psoriasis
AU2011349104A1 (en) Composition for the treatment of skin conditions
Van et al. COMPARATION OF THE EFFICACY OF ORAL IVERMECTIN COMBINED TOPICAL METRONIDAZOL 1% WITH ORAL AND TOPICAL
Jancin Flu Treatment for Upcoming Season Clarified
AU2006246350A1 (en) Preparation for treating psoriasis
NZ751915B2 (en) Non-irritating ophthalmic povidone-iodine compositions

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION